Statistics for Dermapharm Holding SE (id:2642 DMP)
Valuation metrics
Market cap
2.05B
Enterprise value
2.79B
Trailing P/E (ttm)
22.68
Forward P/E
16.21
PEG ratio
16.21
Price/Sales (ttm)
1.79
Price/Book (mrq)
3.80
Enterprise Value/Revenue
2.44
Enterprise Value/EBITDA
12.84
Overview
Shares outstanding
53.84M
Float
17.00M
Shares short
% Held by insiders
3.00%
% Held by institutions
3.00%
Average volume (10 days)
40.49K
Average volume (90 days)
Price summary
52-Week low
30.15
52-Week high
43.22
52-Week change
-12.06%
Beta
1.14
50-Day moving average
34.16
200-Day moving average
34.64
Dividends and splits
Forward annual dividend rate
3.52
Forward annual dividend yield
5.00
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
2.58
Payout ratio
3.00
Dividend date
Ex-dividend date
June 28, 2024
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
7.24%
Operating margin
10.03%
Operational effectiveness
Return on assets
5.71%
Return on equity
15.00%
Income statement
Revenue (ttm)
21.25
Revenue per share (ttm)
21.25
Quarterly revenue growth (yoy)
5.00
Gross profit (ttm)
719.16M
EBITDA
300.62M
Net income to common (ttm)
83.04M
Diluted EPS (ttm)
1.68
Quarterly earnings growth (yoy)
9.54%
Balance sheet
Total cash (mrq)
165.76M
Total cash per share (mrq)
3.07
Total debt (mrq)
1.08B
Total Debt/Equity (mrq)
193.81
Current ratio (mrq)
158.10%
Book value per share (mrq)
10.02
Cash flow
Cash flow statement
187.31M
Levered free cash flow (LFCF)
155.19M